160 related articles for article (PubMed ID: 25968921)
41. Pharmacogenetic determinant of the drug interaction between tacrolimus and omeprazole.
Zhao W; Fakhoury M; Maisin A; Baudouin V; Storme T; Deschênes G; Jacqz-Aigrain E
Ther Drug Monit; 2012 Dec; 34(6):739-41. PubMed ID: 23042259
[TBL] [Abstract][Full Text] [Related]
42. Impact of POR and CYP3A5 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in the Early Post-operative Period Following Kidney Transplantation.
Phupradit A; Vadcharavivad S; Ingsathit A; Kantachuvesiri S; Areepium N; Sra-Ium S; Auamnoy T; Sukasem C; Sumethkul V; Kitiyakara C
Ther Drug Monit; 2018 Oct; 40(5):549-557. PubMed ID: 29878980
[TBL] [Abstract][Full Text] [Related]
43. Effects of Genetic Polymorphism in CYP3A4 and CYP3A5 Genes on Tacrolimus Dose Among Kidney Transplant Recipients.
Yousef AM; Qosa H; Bulatova N; Abuhaliema A; Almadhoun H; Khayyat G; Olemat M
Iran J Kidney Dis; 2016 May; 10(3):156-63. PubMed ID: 27225724
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation.
Anglicheau D; Flamant M; Schlageter MH; Martinez F; Cassinat B; Beaune P; Legendre C; Thervet E
Nephrol Dial Transplant; 2003 Nov; 18(11):2409-14. PubMed ID: 14551375
[TBL] [Abstract][Full Text] [Related]
45. Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient.
Capone D; Tarantino G; Gentile A; Sabbatini M; Polichetti G; Santangelo M; Nappi R; Ciotola A; D'Alessandro V; Renda A; Basile V; Federico S
J Clin Pharm Ther; 2010 Feb; 35(1):121-4. PubMed ID: 20175821
[TBL] [Abstract][Full Text] [Related]
46. Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis.
Zuo XC; Ng CM; Barrett JS; Luo AJ; Zhang BK; Deng CH; Xi LY; Cheng K; Ming YZ; Yang GP; Pei Q; Zhu LJ; Yuan H; Liao HQ; Ding JJ; Wu D; Zhou YN; Jing NN; Huang ZJ
Pharmacogenet Genomics; 2013 May; 23(5):251-61. PubMed ID: 23459029
[TBL] [Abstract][Full Text] [Related]
47. In vivo CYP3A4 activity, CYP3A5 genotype, and hematocrit predict tacrolimus dose requirements and clearance in renal transplant patients.
de Jonge H; de Loor H; Verbeke K; Vanrenterghem Y; Kuypers DR
Clin Pharmacol Ther; 2012 Sep; 92(3):366-75. PubMed ID: 22871995
[TBL] [Abstract][Full Text] [Related]
48. Nifedipine interaction with tacrolimus in liver transplant recipients.
Seifeldin RA; Marcos-Alvarez A; Gordon FD; Lewis WD; Jenkins RL
Ann Pharmacother; 1997 May; 31(5):571-5. PubMed ID: 9161650
[TBL] [Abstract][Full Text] [Related]
49. Effect of CYP3A5 and ABCB1 polymorphisms on the interaction between tacrolimus and itraconazole in patients with connective tissue disease.
Togashi M; Niioka T; Komatsuda A; Nara M; Okuyama S; Omokawa A; Abumiya M; Wakui H; Takahashi N; Miura M
Eur J Clin Pharmacol; 2015 Sep; 71(9):1091-7. PubMed ID: 26184414
[TBL] [Abstract][Full Text] [Related]
50. A Lack of Significant Effect of POR*28 Allelic Variant on Tacrolimus Exposure in Kidney Transplant Recipients.
Jannot AS; Vuillemin X; Etienne I; Buchler M; Hurault de Ligny B; Choukroun G; Colosio C; Thierry A; Vigneau C; Moulin B; Rerolle JP; Heng AE; Subra JF; Legendre C; Beaune P; Loriot MA; Thervet E; Pallet N
Ther Drug Monit; 2016 Apr; 38(2):223-9. PubMed ID: 26829596
[TBL] [Abstract][Full Text] [Related]
51. Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.
Zhang X; Liu ZH; Zheng JM; Chen ZH; Tang Z; Chen JS; Li LS
Clin Transplant; 2005 Oct; 19(5):638-43. PubMed ID: 16146556
[TBL] [Abstract][Full Text] [Related]
52. A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients.
Elens L; Bouamar R; Hesselink DA; Haufroid V; van der Heiden IP; van Gelder T; van Schaik RH
Clin Chem; 2011 Nov; 57(11):1574-83. PubMed ID: 21903774
[TBL] [Abstract][Full Text] [Related]
53. A systematic review of the effect of CYP3A5 genotype on the apparent oral clearance of tacrolimus in renal transplant recipients.
Barry A; Levine M
Ther Drug Monit; 2010 Dec; 32(6):708-14. PubMed ID: 20864901
[TBL] [Abstract][Full Text] [Related]
54. Dynamic effects of CYP3A5 polymorphism on dose requirement and trough concentration of tacrolimus in renal transplant recipients.
Chen P; Li J; Li J; Deng R; Fu Q; Chen J; Huang M; Chen X; Wang C
J Clin Pharm Ther; 2017 Feb; 42(1):93-97. PubMed ID: 27885697
[TBL] [Abstract][Full Text] [Related]
55. CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III).
Yoon SH; Cho JH; Kwon O; Choi JY; Park SH; Kim YL; Yoon YR; Won DI; Kim CD
Transplantation; 2013 Mar; 95(6):828-34. PubMed ID: 23364483
[TBL] [Abstract][Full Text] [Related]
56. Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: a pilot study.
van Maarseveen EM; Crommelin HA; Mudrikova T; van den Broek MP; van Zuilen AD
Transplantation; 2013 Jan; 95(2):397-402. PubMed ID: 23250333
[TBL] [Abstract][Full Text] [Related]
57. Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism--a prospective, randomized, controlled study.
Chen SY; Li JL; Meng FH; Wang XD; Liu T; Li J; Liu LS; Fu Q; Huang M; Wang CX
Clin Transplant; 2013; 27(3):E272-81. PubMed ID: 23432535
[TBL] [Abstract][Full Text] [Related]
58. A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation.
Andrews LM; Hesselink DA; van Gelder T; Koch BCP; Cornelissen EAM; Brüggemann RJM; van Schaik RHN; de Wildt SN; Cransberg K; de Winter BCM
Clin Pharmacokinet; 2018 Apr; 57(4):475-489. PubMed ID: 28681225
[TBL] [Abstract][Full Text] [Related]
59. Individualized Tacrolimus Therapy for Pediatric Nephrotic Syndrome: Considerations for Ontogeny and Pharmacogenetics of CYP3A.
Sun JY; Xu ZJ; Sun F; Guo HL; Ding XS; Chen F; Xu J
Curr Pharm Des; 2018; 24(24):2765-2773. PubMed ID: 30156148
[TBL] [Abstract][Full Text] [Related]
60. Increased tacrolimus trough levels in association with severe diarrhea, a case report.
Asano T; Nishimoto K; Hayakawa M
Transplant Proc; 2004 Sep; 36(7):2096-7. PubMed ID: 15518758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
